Edit Entry | Edit CV

Anna N. A. Tosteson, ScD

Professor of The Dartmouth Institute
Professor of Medicine
Professor of Community and Family Medicine
James J. Carroll 1948 Professor of Oncology

Additional Titles/Positions/Affiliations
Director, Comparative Effectiveness Research Program, The Dartmouth Institute for Health Policy and Clinical Practice
Associate Director for Population Sciences, Dartmouth Cancer Center
Principal Investigator, SYNERGY, Dartmouth's Clinical and Translational Science Institute

The Dartmouth Institute
Community and Family Medicine

Biostatistics (Health Decision Sciences), Harvard University, ScD
Biostatistics, Harvard University, MS
Statistics & Biometry, Cornell University, BS

Dartmouth Cancer Center
The Dartmouth Institute for Health Policy and Clinical Practice

Academic Analytics
View Profile

Contact Information

Geisel School of Medicine at Dartmouth
One Medical Center Drive
Lebanon NH 03756

Office: WTRB 526, DHMC
Phone: 603-646-5664
Email: Anna.Tosteson@dartmouth.edu

Assistant: Christopher Jacobs
Asst. Phone: 603-646-5237
Asst. Email: Christopher.R.Jacobs@Dartmouth.EDU

Professional Interests

Dr. Anna Tosteson is a decision scientist and health services researcher who studies how the diffusion of innovations in health care are changing health, costs and quality of care. Through study of diverse data sources including registries, electronic health record data, clinical and epidemiological studies, and administrative claims data, she seeks insights into the long-term clinical and economic effects of alternative approaches to health care delivery with a focus on cancer screening, musculoskeletal disease, and women’s health.

Grant Information

Promoting follow-up of abnormal cancer screening tests using population-based systems to support stepped care multilevel intervention. (NCI: U01CA225451 )

Risk-based breast cancer screening and surveillance in community practice. (NCI, P01CA154292)

Courses Taught

PH 119/121; QBS 140 Decision and Cost-Effectiveness Analysis

Selected Publications


Characterizing the Traveling Oncology Workforce and Its Influence on Patient Travel Burden: A Claims-Based Approach.
Scodari BT, Schaefer AP, Kapadia NS, O'Malley AJ, Brooks GA, Tosteson ANA, Onega T, Wang C, Wang F, Moen EL
JCO Oncol Pract. 2024 Feb 22;:OP2300690. doi: 10.1200/OP.23.00690. Epub 2024 Feb 22.
PMID: 38386962

Response to Omoleye, Esserman, Olufunmilayo.
Kerlikowske K, Zhu W, Su YR, Sprague BL, O'Meara ES, Tosteson ANA, Wernli KJ, Miglioretti DL
J Natl Cancer Inst. 2024 Jan 16; pii: djae011. doi: 10.1093/jnci/djae011. Epub 2024 Jan 16.
PMID: 38230817

Screening Beyond the Evidence: Patterns of Age and Comorbidity for Breast, Cervical, and Colorectal Cancer Screening.
Onega T, Garcia M, Beaber EF, Haas JS, Breslau ES, Tosteson ANA, Halm E, Chao CR, Barlow WE
J Gen Intern Med. 2023 Dec 14; doi: 10.1007/s11606-023-08562-0. Epub 2023 Dec 14.
PMID: 38097863

The Association of Rural Residence With Surgery and Adjuvant Radiation in Medicare Beneficiaries With Rectal Cancer.
Sha ST, Usadi B, Wang Q, Tomaino M, Brooks GA, Loehrer AP, Wong SL, Tosteson ANA, Colla CH, Kapadia NS
Adv Radiat Oncol. 2023 Nov-Dec;8(6):101286. doi: 10.1016/j.adro.2023.101286. Epub 2023 Jun 8.
PMID: 38047230

Supplemental magnetic resonance imaging plus mammography compared with magnetic resonance imaging or mammography by extent of breast density.
Kerlikowske K, Zhu W, Su YR, Sprague BL, Stout NK, Onega T, O'Meara ES, Henderson LM, Tosteson ANA, Wernli K, Miglioretti DL
J Natl Cancer Inst. 2024 Feb 8;116(2):249-257. doi: 10.1093/jnci/djad201.
PMID: 37897090

A Multilevel Primary Care Intervention to Improve Follow-Up of Overdue Abnormal Cancer Screening Test Results: A Cluster Randomized Clinical Trial.
Atlas SJ, Tosteson ANA, Wright A, Orav EJ, Burdick TE, Zhao W, Hort SJ, Wint AJ, Smith RE, Chang FY, Aman DG, Thillaiyapillai M, Diamond CJ, Zhou L, Haas JS
JAMA. 2023 Oct 10;330(14):1348-1358. doi: 10.1001/jama.2023.18755.
PMID: 37815566

Digital mammography and digital breast tomosynthesis for detecting invasive lobular and ductal carcinoma.
Onega T, Abraham L, Miglioretti DL, Lee CI, Henderson LM, Kerlikowske K, Tosteson ANA, Weaver D, Sprague BL, Bowles EJA, di Florio-Alexander RM
Breast Cancer Res Treat. 2023 Dec;202(3):505-514. doi: 10.1007/s10549-023-07051-6. Epub 2023 Sep 11.
PMID: 37697031

Broadband Data Forensics: Spatiotemporal Variations of the Download/Upload Speed Metric Commonly Used to Evaluate Potential Telehealth Accessibility.
Alford-Teaster J, Wang F, Moen EL, Cowan L, Smith RE, Tosteson ANA, Onega T
Telemed J E Health. 2023 Sep 4; doi: 10.1089/tmj.2023.0320. Epub 2023 Sep 4.
PMID: 37668655

A Survey of Cancer Risk Behaviors, Beliefs, and Social Drivers of Health in New Hampshire and Vermont.
Skipper TA, Weiss JE, Carlos HA, Gunn CM, Hasson RM, Peacock JL, Schiffelbein JE, Tosteson ANA, Lansigan F, Rees JR
Cancer Res Commun. 2023 Aug;3(8):1678-1687. doi: 10.1158/2767-9764.CRC-23-0267. Epub 2023 Aug 29.
PMID: 37649812

Cancer Epidemiology in the Northeastern United States (2013-2017).
Rees JR, Weiss JE, Gunn CM, Carlos HA, Dragnev NC, Supattapone EY, Tosteson ANA, Kraft SA, Vahdat LT, Peacock JL
Cancer Res Commun. 2023 Aug;3(8):1538-1550. doi: 10.1158/2767-9764.CRC-23-0152. Epub 2023 Aug 14.
PMID: 37583435

View more publications on PubMed